Synthetic DNA-Based Drug Is First To Slow Progress of Huntington’s Disease Published on December 12, 2017 at 04:30AM John.Banister writes: The Guardian reports of early success in the trial of a synthetic DNA based drug, Ionis-HTTRx, at University College London’s Huntington’s Disease Center. Bionews explains that this gene silencing drug binds to the RNA transcript …
Continue reading “Synthetic DNA-Based Drug Is First To Slow Progress of Huntington’s Disease”